BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 31986228)

  • 1. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.
    Pergolizzi JV; Raffa RB; Rosenblatt MH
    J Clin Pharm Ther; 2020 Oct; 45(5):892-903. PubMed ID: 31986228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol.
    Kudrich C; Hurd YL; Salsitz E; Wang AL
    Cannabis Cannabinoid Res; 2022 Oct; 7(5):569-581. PubMed ID: 34678050
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of depression on opioid withdrawal symptoms among smokers with opioid use disorder receiving medication-assisted opioid detoxification.
    Abarno CN; Chapman HM; Copeland AL
    Exp Clin Psychopharmacol; 2023 Apr; 31(2):370-377. PubMed ID: 36074624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment.
    Kosten TR; Baxter LE
    Am J Addict; 2019 Feb; 28(2):55-62. PubMed ID: 30701615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunctive memantine for opioid use disorder treatment: A systematic review.
    Elias AM; Pepin MJ; Brown JN
    J Subst Abuse Treat; 2019 Dec; 107():38-43. PubMed ID: 31757263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sources and Main Motivations for Prescription Opioid Misuse Among Reproductive-Aged Parenting Women in the United States.
    Sanmartin MX; Ali MM; Novak P; Chen J
    Subst Use Misuse; 2019; 54(8):1332-1336. PubMed ID: 30860931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain.
    Weiss RD; Potter JS; Griffin ML; McHugh RK; Haller D; Jacobs P; Gardin J; Fischer D; Rosen KD
    J Subst Abuse Treat; 2014 Aug; 47(2):140-5. PubMed ID: 24814051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High enhancer, downer, withdrawal helper: Multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City.
    Mateu-Gelabert P; Jessell L; Goodbody E; Kim D; Gile K; Teubl J; Syckes C; Ruggles K; Lazar J; Friedman S; Guarino H
    Int J Drug Policy; 2017 Aug; 46():17-27. PubMed ID: 28577506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid tapering in patients with prescription opioid use disorder: A retrospective study.
    Zhou K; Jia P; Bhargava S; Zhang Y; Reza T; Peng YB; Wang GG
    Scand J Pain; 2017 Oct; 17():167-173. PubMed ID: 28988103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence.
    Dunn KE; Huhn AS; Bergeria CL; Gipson CD; Weerts EM
    J Pharmacol Exp Ther; 2019 Nov; 371(2):422-452. PubMed ID: 31391211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between frequency of opioid misuse and opioid use disorder among youth and adults in the United States.
    Elliott KR; Jones E
    Drug Alcohol Depend; 2019 Apr; 197():73-77. PubMed ID: 30784951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition and management of iatrogenically induced opioid dependence and withdrawal in children.
    Galinkin J; Koh JL; ; ;
    Pediatrics; 2014 Jan; 133(1):152-5. PubMed ID: 24379233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid withdrawal: role in addiction and neural mechanisms.
    Monroe SC; Radke AK
    Psychopharmacology (Berl); 2023 Jul; 240(7):1417-1433. PubMed ID: 37162529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age of initiation, psychopathology, and other substance use are associated with time to use disorder diagnosis in persons using opioids nonmedically.
    Schepis TS; Hakes JK
    Subst Abus; 2017; 38(4):407-413. PubMed ID: 28723266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical Withdrawal Symptoms after Abrupt Tramadol Discontinuation: A Case Report.
    Sams C; Cheng S
    J Pain Palliat Care Pharmacother; 2023 Dec; 37(4):321-323. PubMed ID: 37791819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?
    Tabanelli R; Brogi S; Calderone V
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adults who misuse opioids: Substance abuse treatment use and perceived treatment need.
    Choi NG; DiNitto DM; Marti CN; Choi BY
    Subst Abus; 2019; 40(2):247-255. PubMed ID: 30810503
    [No Abstract]   [Full Text] [Related]  

  • 18. Weaning From Long-term Opioid Therapy.
    Moss C; Bossano C; Patel S; Powell A; Chan Seay R; Borahay MA
    Clin Obstet Gynecol; 2019 Mar; 62(1):98-109. PubMed ID: 30601171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.
    Bisaga A; Mannelli P; Sullivan MA; Vosburg SK; Compton P; Woody GE; Kosten TR
    Am J Addict; 2018 Apr; 27(3):177-187. PubMed ID: 29596725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
    Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
    Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.